Latest Period
n/a
Security Snapshot
SpyGlass Pharma, Inc. - Common Stock, $0.00001 par value per share (SGP) Institutional Ownership
CUSIP: 85220G109
13F Institutional Holders and Ownership History
Institutions Reporting
Shares (Excl. Options)
Price
$26.42
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Symbol
- SGP on Nasdaq
- Shares outstanding
- 33,491,317
- Price per share
- $26.42
Quick Takeaways
- SGP - SpyGlass Pharma, Inc. - Common Stock, $0.00001 par value per share is tracked under CUSIP 85220G109.
- Latest finished 13F holder period is not available.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Quarterly ownership records are not available yet for this CUSIP.
- This page updates as SEC-backed holdings history becomes available.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 85220G109?
CUSIP 85220G109 identifies SGP - SpyGlass Pharma, Inc. - Common Stock, $0.00001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Significant Owners of SpyGlass Pharma, Inc. - Common Stock, $0.00001 par value per share (SGP) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 24% | 8,022,639 | RA Capital Management, L.P. | 09 Feb 2026 | ||||
| New Enterprise Associates 17, L.P. | 22% | 7,393,823 | Ali Behbahani | 09 Feb 2026 | ||||
| Vensana Capital I GP, LLC | 9.9% | 3,312,141 | Kirk Nielsen | 09 Feb 2026 | ||||
| Sands Capital Life Sciences Pulse Fund III (DE), L.P. | 7.8% | 2,500,012 | SANDS FRANK M. | 06 Feb 2026 | ||||
| Gilde Healthcare Holding B.V. | 6.6% | 2,187,513 | Gilde Healthcare Holding B.V. | 09 Feb 2026 | ||||
| Samsara BioCapital, L.P. | 6.3% | 2,109,953 | Srinivas Akkaraju | 09 Feb 2026 |